Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

A preliminary study of the anti-cancer effect of tanshinone on hepatic cancer and its mechanism of action in mice

  • 21 Accesses

  • 4 Citations

Abstract

Objective: There were some experimental researchesin vitro, which showed that tanshinonoe (Tan) had cytotoxic activities against some cancer cell lines. But there was no report of anti-cancer activity of Tanin vivo. This experimental study was performed to confirm the anti-cancer activity of Tanin vivo. Methods: Hepatic carcinoma H22 bearing mice were treated with DMSO, 5-Fu, and Tan, at the end of experiment, the mice were sacrificed, tumor tissues were separated and weighed, and the tumor inhibitory rate was calculated, 3 times of the same experiments were performed. The proliferating kinetics of hepatic carcinoma H22 cells in mice was measured by bromodeoxyuridine labelingin vivo and immunohistochemical staining of the proliferating cell nuclear antigen (PCNA) in tumor tissues. Results: The tumor inhibitory rates of Tan were 50.0%, 38.5%, and 40.6% in 3 experiments, respectively, compared with those of the DMSO-treated control groups, the differences were significant statistically (P<0.01). The Brdu labeling and PCNA positive cells were 51.8±7.9 and 451.1±26.1, respectively, which were significantly lower than those of controls (84.4±24.3, 694.8±117.1) (P<0.01). Conclusion: Tan had anti-cancer effect on hepatic carcinomain vivo; The mechanisms of action might be associated with inhibition of DNA synthesis, PCNA expression and DNA polymerase δ activity of tumor cells.

This is a preview of subscription content, log in to check access.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. 3.

    Chang WL, Chen CF. Cytotoxic activity of tanshinone against human carcinoma cell lines. Am J Chin Med 1991; 19(3–4): 207.

  2. 4.

    Yuan Shulan, Huang Guangqi, Wang Xiujie, et al. The differentiation inducing effect of tanshinone and retinoic acid on human cervical carcinoma cell line (ME180)in vitro. Chin J Cancer Res 1996; 8(4): 244.

  3. 5.

    Van Diereendonck JH, Cornelisse CJ, Wilem PG, et al. characterization of a slow-growing, transplantable rat mammary tumor (MC-83): a model for endocrine-related cell kinetic studies. Cancer Res 1987; 47: 4093.

  4. 6.

    Connolly KM, Bogdanffy MS. Evaluation of proliferation cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual stain comparison with 5-bromo-2′-deoxyuridine. J Histochem Cytochem 1993; 41: 1.

  5. 7.

    Teodori L, Trinca ML, Goghde W, et al. Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (Brdu) monoclonal antibody method: comparison with DNA cytometric data. Int J Cancer 1990; 45: 995.

  6. 8.

    Bravo R, Frank R, Blundell PA, et al. Cyclin/PCNA is the auxiliary protein of DNA polymerase. Nature 1987; 326: 515.

  7. 9.

    Del Bino G. Morphological and clinical significance of cell kinetics in non-Hodgkins lymphomas. Basic Appl Histochem 1986; 30: 197.

Download references

Author information

Additional information

This work was supported by the Science Found of the Ministry of Public Health. (96-1-240)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wang, X., Yuan, S., Wang, C. et al. A preliminary study of the anti-cancer effect of tanshinone on hepatic cancer and its mechanism of action in mice. Chinese Journal of Cancer Research 10, 100 (1998). https://doi.org/10.1007/BF02954016

Download citation

Key words

  • Tanshinone
  • Anti-cancer effect
  • Hepatic neoplasms